Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials

Autor: Parodis, Ioannis, Lindblom, Julius, Levy, Roger A *, Zen, Margherita, Cetrez, Nursen, Gomez, Alvaro, Oon, Shereen, Henning, Christine, Khamashta, Munther, Quasny, Holly A, Chauhan, Deven, Askanase, Anca, van Vollenhoven, Ronald, Nikpour, Mandana
Zdroj: In The Lancet Rheumatology November 2024 6(11):e751-e761
Databáze: ScienceDirect